Related Experiment Video

Updated: Jul 9, 2025

In Vitro 3D Cell-Cultured Arterial Models for Studying Vascular Drug Targeting Under Flow
07:00

In Vitro 3D Cell-Cultured Arterial Models for Studying Vascular Drug Targeting Under Flow

Published on: March 14, 2021

3.3K

Advances in Natural and Bio-Inspired Nanoparticles for the Treatment of Cardiovascular Diseases

Mariana Varna1, Manuela Calin2, Ille C Gebeshuber3

  • 1Paris-Saclay University, Institut Galien Paris-Saclay, CNRS UMR 8612, Pole Biologie-Pharmacie-Chimie, Bâtiment Henri Moissan, 6 Rue d'Arsonval, 91400 Orsay, France.

Nanomaterials (Basel, Switzerland)
|December 8, 2023
PubMed

Insights

Cardiovascular diseases (CVD) impact heart and blood vessels, causing significant global disability and death. Understanding CVD is crucial for public health and medical research.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Cardiovascular diseases (CVD) are a leading cause of mortality and morbidity globally.
  • These conditions encompass a range of disorders affecting the heart and blood vessels.
  • CVD poses a significant public health challenge, necessitating further research and intervention.

More Related Videos

Capillary Force Lithography for Cardiac Tissue Engineering10:09

Capillary Force Lithography for Cardiac Tissue Engineering

Published on: June 10, 2014

12.5K
Harmonic Nanoparticles for Regenerative Research09:23

Harmonic Nanoparticles for Regenerative Research

Published on: May 1, 2014

11.7K

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.9K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436